Literature DB >> 20155379

Myocardial MIBG scintigraphy: a useful clinical tool? : A retrospective study in 50 parkinsonian patients.

Ines Fröhlich1, Wilfried Pilloy, Michel Vaillant, Nico J Diederich.   

Abstract

Meta-iodbenzylguanidine scintigraphy (MIBG scintigraphy) shows reduced uptake in idiopathic Parkinson's disease (IPD), idiopathic REM sleep behavior disorder (IRBD) and Lewy body dementia (LBD), but not in other parkinsonian or dementia syndromes. We retrospectively reevaluated 50 patients. Concordance rate between last clinical diagnosis and scintigraphy diagnosis was only given in two-thirds of the patients. Confounding factors were: decreasing heart/mediastinum ratio (HMR) with progressive age, higher HMR in women and possibly interference with antihypertensive medication. Standardization of the methods and precise clinical guidelines are warranted for better clinical use.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20155379     DOI： 10.1007/s10072-010-0218-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  19 in total

1.  Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.

Authors:  Kenichi Kashihara; Manabu Ohno; Sanami Kawada; Yoshihiro Okumura
Journal:  J Nucl Med       Date:  2006-07       Impact factor: 10.057

2.  Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.

Authors:  Joong-Seok Kim; Phil-Hyu Lee; Kwang-Soo Lee; Jeong-Wook Park; Yeong-In Kim; Yong-An Chung; Sung-Hoon Kim; Seung-Hyun Kim; Juhan Kim; Yun-Young Choi; Hee-Tae Kim
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

3.  Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.

Authors:  M Yoshita; J Taki; K Yokoyama; M Noguchi-Shinohara; Y Matsumoto; K Nakajima; M Yamada
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

Review 4.  The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.

Authors:  S Braune
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Cardiac 123I-MIBG scintigraphy in patients with essential tremor.

Authors:  Phil Hyu Lee; Ji Won Kim; Oh Young Bang; In Soo Joo; Seok-Nam Yoon; Kyoon Huh
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

7.  Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.

Authors:  Martin Köllensperger; Klaus Seppi; Claudia Liener; Sylvia Boesch; Dirk Heute; Katherina J Mair; Joerg Mueller; Martin Sawires; Christoph Scherfler; Michael F Schocke; Eveline Donnemilier; Irene Virgolini; Gregor K Wenning; Werner Poewe
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

8.  Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.

Authors:  Frédéric Courbon; Christine Brefel-Courbon; Claire Thalamas; Marie-Jeanne Alibelli; Isabelle Berry; Jean-Louis Montastruc; Olivier Rascol; Jean-Michel Senard
Journal:  Mov Disord       Date:  2003-08       Impact factor: 10.338

9.  Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease.

Authors:  Mamoru Shibata; Yoko Morita; Toshihiko Shimizu; Kazushi Takahashi; Norihiro Suzuki
Journal:  J Neurol Sci       Date:  2008-10-05       Impact factor: 3.181

10.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910
View more
  5 in total

Review 1.  MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.

Authors:  Giorgio Treglia; Ernesto Cason; Antonella Stefanelli; Fabrizio Cocciolillo; Daniela Di Giuda; Giorgio Fagioli; Alessandro Giordano
Journal:  Clin Auton Res       Date:  2011-07-27       Impact factor: 4.435

2.  The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson's Disease from Other Parkinsonian Syndromes.

Authors:  Eiji Matsusue; Yoshio Fujihara; Kenichiro Tanaka; Yuki Aozasa; Manabu Shimoda; Hiroyuki Nakayasu; Kazuhiko Nakamura; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2018-06-18       Impact factor: 1.641

Review 3.  (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.

Authors:  Eun Joo Chung; Sang Jin Kim
Journal:  J Mov Disord       Date:  2015-05-31

4.  Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice.

Authors:  Cornelia Skowronek; Leonora Zange; Axel Lipp
Journal:  Front Neurol       Date:  2019-02-26       Impact factor: 4.003

5.  Cardiac sympathetic innervation in Parkinson's disease versus multiple system atrophy.

Authors:  Christine Eckhardt; Florian Krismer; Eveline Donnemiller; Sabine Eschlböck; Alessandra Fanciulli; Cecilia Raccagni; Sylvia Bösch; Katherina Mair; Christoph Scherfler; Atbin Djamshidian; Christian Uprimny; Bernhard Metzler; Klaus Seppi; Werner Poewe; Stefan Kiechl; Irene Virgolini; Gregor K Wenning
Journal:  Clin Auton Res       Date:  2022-02-11       Impact factor: 5.625
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.